STAT+: 11 people shaping psychedelics drug development
The field of psychedelics, once relegated to the fringes of science and medicine, is in…
Category: psychedelics
STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy
It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and…
STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy
Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by…
Listen: Drug pricing drops & psychedelics under fire
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and…
The politics of mifepristone in the 2024 election
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Three MDMA therapy papers retracted over data integrity concerns
The journal Psychopharmacology has retracted three papers about MDMA-assisted psychotherapy — right on the heels…
Opinion: Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a…
.jpg)
DO NOT PUBLISH: FDA rejects MDMA as a psychedelic treatment for PTSD
The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on…
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax…
STAT+: FDA investigators have not spoken with patients and others alleging misconduct in MDMA trials
At a contentious advisory committee meeting in June, the Food and Drug Administration announced it…
‘Legal’ psychedelic mushrooms actually contain illegal hallucinogens, study shows
WASHINGTON – A new study published Thursday finds that several mushroom candies, which are widely…
STAT+: Don’t write off MDMA yet: How the FDA got on board with psychedelics
Days after an advisory committee resoundingly voted for the Food and Drug Administration to reject…
Opinion: Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
Many people have interpreted as a setback the “no” vote by an advisory committee to…
STAT+: The inside story of how Lykos’ MDMA research went awry
At a heated advisory committee meeting convened by the Food and Drug Administration last week,…
Listen: Psychedelics at the FDA, ASCO recap, & MorphoSys update
How did advisers react to the first psychedelic therapy to go before the Food and…
STAT+: Psychedelics companies see FDA panel’s vote as a growth opportunity, not a roadblock
A day after a panel of advisers to the Food and Drug Administration expressed deep…
STAT+: Tracking the FDA advisory panel on MDMA therapy for PTSD
Good morning, and welcome to STAT’s live blog of the Food and Drug Administration’s scientific…
What to watch for in the crucial FDA meeting on MDMA therapy for PTSD
In less than three months, the Food and Drug Administration will decide whether to approve…
STAT+: After MDMA therapy, she considered suicide. The trial data tell a different story
The MDMA study was her last hope. She had read headlines celebrating a 83% response…
Opinion: Lessons to psychiatrists-in-training from the CIA’s mind-control projects
My chief resident gave me a strange look when I arrived for another day of…
STAT+: The quest for psychedelics in the Amazon would push a Harvard botanist to his limits
The Aztecs called it teonanácatl, or “flesh of the Gods.” Some who ate the intoxicating…
STAT+: A Harvard-affiliated hospital is testing magic mushrooms on dying patients
Sixty years after Harvard fired Timothy Leary over his experiments with psychedelic drugs, a hospital…
Mind-altering ketamine becomes latest pain treatment, despite little research or regulation
WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option…
STAT+: New study adds to evidence on psychedelic as effective treatment for PTSD
MDMA is a safe and effective treatment for post-traumatic stress disorder in a racially and…
Opinion: I cured my ARFID with psilocybin. I shouldn’t have needed to self-treat it
For 27 years, I tried to make myself eat vegetables. Last fall, I ate my…
STAT+: One dose of psilocybin may have lasting effects on major depression, study finds
A single dose of psilocybin may have enduring benefits for people with major depressive disorder,…
How the political right came to back psychedelics to treat trauma
DENVER — When former Texas Gov. Rick Perry strode onto the stage at the largest…
As psychedelics near approval, there’s no consensus on how they work
DENVER — The founder of Field Trip, a chain of shuttered ketamine clinics currently facing…
STAT+: Counter-culture or pharma: Group behind MDMA therapy for PTSD wrestles with its identity
DENVER — He could have been a rock star, a religious icon, the way ecstatic…
STAT+: Ketamine clinics’ bust serves as warning of business challenge facing psychedelic therapy
A chain of luxury ketamine clinics called Field Trip started churning through business strategies at…
A half century after Prozac, a new generation of depression drugs is bringing hope to a long-stagnant field
This article is excerpted from the latest STAT Report: Treating Depression: a new era of…
‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down
Around 4:30 p.m. last Friday, Ketamine Wellness Centers CEO Kevin Nicholson sent an email: In…
Opinion: The second age of psychedelic therapies for mental health
Psychedelics like psilocybin and ketamine are being touted as the next generation of treatment for…
Psychedelic therapy is moving to the next frontier: workplace perk
Acupuncture and chiropractic care weren’t always the common fixtures of employer benefit plans they are…
Opinion: Breakthrough Therapies Act: Good idea, wrong solution
The Breakthrough Therapies Act, recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.)…
Colorado poised to become second state with legalized ‘medicinal psychedelics’
Colorado looks set to legalize magic mushrooms in this week’s midterm elections, with the group…
‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability
The hype around psychedelic therapy has been put to the test, with the publication Wednesday…
Virtual drug screening identifies possible new antidepressants in LSD-like molecules
What’s a hallucinogen without the hallucinations? Perhaps a potent and fast-acting antidepressant, according to a…
Psilocybin shows promise for treating alcohol addiction, new study finds
Taking one recreational drug as treatment for over-dependence on another is hardly intuitive, but a…
Opinion: Psychedelics researchers and investors should focus on delivering therapy, not drugs
“How To Change Your Mind,” a new four-part documentary about psychedelics, has been hovering around…
Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals
Psychedelic medicine is having a moment of tremendous growth and innovation as researchers rediscover its…
Psychedelic medicine group investigating a board member accused of financial elder abuse
A leading psychedelics organization has launched an investigation of one of its board members after…
A psychedelic therapist allegedly took millions from a Holocaust survivor, highlighting worries about elders taking hallucinogens
He made a new life for himself in California. After surviving the Holocaust and growing…
‘It’s not medical’: Oregon wrestles with how to offer psychedelics outside the health care system
PORTLAND, Ore. — Visitors to the fabric store, kitty-corner to a Whole Foods, are greeted…